IL-17B Protein, Human, Recombinant (hFc) V2

一键复制产品信息

SPR兼容缓冲液

货号 TMPY-00400U

IL-17B Protein, Human, Recombinant (hFc) V2 is expressed in HEK293 Cells. The accession number is Q9UHF5.

IL-17B Protein, Human, Recombinant (hFc) V2

一键复制产品信息

SPR兼容缓冲液

货号 TMPY-00400U

IL-17B Protein, Human, Recombinant (hFc) V2 is expressed in HEK293 Cells. The accession number is Q9UHF5.

规格	价格	库存
5 μg	¥ 389	6-8日内发货
10 μg	¥ 628	6-8日内发货
20 μg	¥ 987	5日内发货
50 μg	¥ 1,980	5日内发货
100 μg	¥ 3,430	5日内发货
200 μg	¥ 5,890	5日内发货
500 μg	¥ 12,700	5日内发货
1 mg	¥ 22,400	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

资源下载

重组蛋白用户指南

产品信息

生物活性	Immobilized Human IL-17B, hFc Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-IL-17B Antibody, hFc Tag with the EC50 of 18.0 ng/ml determined by ELISA.
产品描述	IL-17B Protein, Human, Recombinant (hFc) V2 is expressed in HEK293 Cells. The accession number is Q9UHF5.
种属	Human
表达系统	HEK293 Cells
标签	C-hFc
蛋白编号	Q9UHF5
别名	ZCYTO7,NIRF,interleukin 17B,IL-20,IL-17B
蛋白构建	Gln21-Phe180
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
分子量	44.91 kDa (Predicted); 50-60 kDa (Due to glycosylation)
内毒素	< 1.0 EU/μg of the protein as determined by the LAL method.
蛋白性状	Lyophilized powder
缓冲液	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
复溶方法	Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/mL. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
存储	Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	IL-17A, the prototypic member of the IL-17 family, several experimental findings strongly support the role of the IL-17B/IL-17 receptor B (IL-17RB) pathway in tumorigenesis and resistance to anticancer therapies. IL-17B/IL-17RB expression patterns and biological activities in cancer and highlight issues that remain to be addressed to better characterize IL-17B and its receptor as potential targets for enhancing the effectiveness of the existing cancer therapies.